Cancer Staging
The ICD-9 code 174 does not specify the staging of breast cancer; therefore, we included information of "secondary and unspecified malignant neoplasm" (ICD-9 codes: 196, 197, and 198) and selected those with no secondary and unspecified malignant neoplasm at cancer diagnosis as patients with early stage breast cancer.
Osteoporosis Medication
As for osteoporosis medicine, we included 5 bisphosphonates: alendronate, etidronate, ibandronic, pamidronate, and zoledronic acid; and 5 non-bisphosphonate drugs: calcitonin, denosumab, estrogen, raloxifene, and teriparatide. Risedronate and bazedoxifene were not prescribed in Taiwan from 2002 to 2013.
Mortality
As enrollment in the NHI program is compulsory for Taiwanese citizens, withdrawal from the program is often due to death of the enrollee.
1,2 However, we followed a more cautious procedure and included 5 additional criteria to define mortality. First, we included mortality information from the Catastrophic Illness Program, if the patient was enrolled in this program. Second, discharge reasons for hospitalized patients were death, suicide, or critical illness. Third, the patient was voluntarily discharged from the hospital against medical advice and then was removed from the NHI program in 28 days. Fourth, the patient was critically ill in the emergency department and received cardiopulmonary resuscitation, electrical defibrillation or cardioversion, endotracheal tube insertion, or epinephrine or norepinephrine injection and then was removed from the NHI program in 28 days. Fifth, we further required those patients who met the aforementioned criteria to have no visits and treatments in their medical records after NHI disenrollment.
eMethods 3. Definition of Osteoporosis Therapy
Osteoporosis therapy is defined as a treatment started before the diagnosis of breast cancer with at least 180 days' use of osteoporosis drugs in 1 year; the quantities of drugs were calculated according to the WHO's Defined Daily Dose system. We employed a dynamic programming algorithm to determine the medical adherence to osteoporosis therapy.
The "no therapy" group comprises those who had established osteoporosis before the diagnosis of breast cancer but were never prescribed any medicine before breast cancer diagnosis. Results are expressed as N, or n. (%). Bone and bone marrow were most likely to be the first sites of distant metastasis for both exposed and unexposed groups.
a Total number of patients with any type of metastasis.
